Identifikatu
Taldeak
Ikertzaileak
Emaitzak
HOSPITAL UNIVERSITARIO RUBER
Saila
Humboldt University of Berlin
Berlín, Alemania
Hemen zaude
Lankidetzak
Humboldt University of Berlin
Humboldt University of Berlin-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2019
Three-year follow-up from a phase 3 study of SB3 (a trastuzumab biosimilar) versus reference trastuzumab in the neoadjuvant setting for human epidermal growth factor receptor 2–positive breast cancer
European Journal of Cancer, Vol. 120, pp. 1-9
Kontaktua
Lege-oharra
Laguntza
translate
eu
arrow_drop_down
translate
eu
arrow_drop_down
es
ca
gl
en
fr
de